• 中国核心期刊数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

中国医药导刊 ›› 2024, Vol. 26 ›› Issue (11): 1132-1138.

• 临床医药 • 上一篇    下一篇

丁苯酞联合间歇性Theta爆发式经颅磁刺激对缺血性卒中后认知障碍患者的疗效观察

张蔚嘉, 马忠良, 薛孟周, 夏彬*   

  1. 郑州大学第二附属医院神经康复科,河南 郑州 450014
  • 收稿日期:2024-11-01 修回日期:2024-11-27 出版日期:2024-11-28 发布日期:2024-11-28
  • 基金资助:
    国家自然科学基金项目(82071331);河南省医学科技攻关联合共建项目(LHG20220464)

Efficacy of Butylphthalide Combined with Intermittent Theta Burst Transcranial Magnetic Stimulation in Patients with Cognitive Impairment after Ischemic Stroke

  1. Department of Neurological Rehabilitation the Second Affiliated Hospital of Zhengzhou University
    Henan Zhengzhou 450014, China
  • Received:2024-11-01 Revised:2024-11-27 Online:2024-11-28 Published:2024-11-28

摘要:

目的:探讨丁苯酞联合间歇性Theta爆发式经颅磁刺激(iTBS)对缺血性卒中后认知障碍患者的疗效。方法:选取20238月至20248月在我院住院治疗的105例缺血性卒中后认知障碍患者,采用随机数字表法将患者随机分成丁苯酞组、iTBS组、联合组,每组各35例。丁苯酞组给予常规治疗及丁苯酞胶囊治疗;iTBS组给予常规治疗及iTBS治疗;联合组给予常规治疗、丁苯酞及iTBS治疗;治疗4周后评估3组患者疗效、认知功能、抑郁状态、炎症指标及脑血流动力学的改善情况。结果:治疗后3组患者各项指标均优于治疗前,且治疗后联合组患者疗效优于丁苯酞组、iTBS组(P<0.05);治疗后组间比较,联合组患者简易智力精神状态检查量表、蒙特利尔认知评估量表、改良Barthel指数、汉密尔顿抑郁量表评分优于丁苯酞组、iTBS组患者(P<0.05);联合组患者C反应蛋白、同型半胱氨酸水平低于丁苯酞组、iTBS组患者(P<0.05);联合组患者平均血液流速、搏动指数优于丁苯酞组、iTBS组患者(P<0.05);3组患者治疗过程中均未产生不良反应。结论:联合使用丁苯酞、iTBS治疗较两者单独使用可更好改善缺血性卒中后认知障碍患者的认知功能、抑郁程度,降低炎症反应,改善脑血流灌注,提高患者日常生活能力,且安全性良好。


关键词: 脑卒中, 认知障碍, 重复经颅磁刺激, 间歇性Theta爆发式经颅磁刺激, 认知功能

Abstract:

Objective: To investigate the efficacy of butylphthalide combined with intermittent theta burst transcranial magnetic stimulation iTBS in patients with cognitive impairment after ischemic stroke.Methods: A total of 105 patients with post-ischemic stroke cognitive impairment who hospitalized in our hospital from August 2023 to August 2024 were selected and the patients were divided into the butylphthalide group iTBS group and combination group according to random number table method with 35 cases in each group. The butylphthalide group was treated with conventional treatment and butylphthalide capsules. The iTBS group was given conventional treatment and iTBS treatment. The combination group was treated with conventional treatment butylphthalide capsule and iTBS. After 4 weeks of treatment the improvement of cognitive function depressive state inflammatory indicates and cerebral hemodynamics was evaluated in the three groups.Results: The therapeutic indexes of the three groups after the treatment were better than those before treatment and the scores of the mini-mental state examination montreal cognitive assessment scale modified barthel index and hamilton depression scale in the combined group were better than those in the butylphthalide group and the iTBS group P<0.05. After treatment the levels of C-reactive protein and homocysteine in the combined group were lower than those in the butylphthalide group and iTBS group P<0.05. After treatment the average blood flow rate and pulse index of the combined group were better than those of the butylphthalide group and the iTBS group P<0.05. There were no adverse reactions in the three groups during treatment.Conclusion: Compared with use alone the combined use of butylphthalide and iTBS can better improve the cognitive function and depression of patients with cognitive impairment after ischemic stroke reduce inflammatory response improve cerebral blood perfusion and improve patients' daily living ability and the safety is good.


Key words:  , Stroke , Cognitive impairment , Repetitive transcranial magnetic stimulation , Intermittent theta burst stimulation , Cognitive function

中图分类号: